Company Number: 15257892

Analysis Date: 2025-07-29 13:34 UTC

Financial Health Assessment for CASCADE MEDTECH LTD

---

1. Financial Health Score: D

Explanation:
The company shows a financial position where liabilities outweigh assets by £1,000, resulting in negative net assets. This indicates early-stage financial distress symptoms, typical of a startup with limited operating history and reliance on director loans. The lack of operating assets or revenues and ongoing liabilities suggest a fragile financial condition needing careful management.

---

2. Key Vital Signs

Metric	Value	Interpretation
Fixed Assets	£0	No long-term assets; typical for a newly formed company with no capital investments yet.
Current Assets	£0	No cash, debtors, or stock; indicates no operating liquidity or revenue generation.
Current Liabilities	£1,000	Amount owed within one year, specifically director loans recorded as creditors.
Net Current Assets	-£1,000	Negative working capital; liabilities exceed short-term assets, showing liquidity strain.
Net Assets (Total Equity)	-£1,000	Negative equity; business owes more than it owns, a symptom of early financial weakness.
Shareholders’ Funds	-£1,000	Reflects negative retained earnings or capital; in this case, loaned funds create a liability.
Employees	0	No staff; likely pre-revenue phase or service-based with directors providing initial funding.

Vital Signs Interpretation:
The absence of assets and presence of director loans as liabilities indicate that the company is in its infancy, relying on shareholder support rather than operational cash flow. The negative net assets are a warning flag—like a patient showing signs of strain—but given the company's recent incorporation date, this is not uncommon.

---

3. Diagnosis

CASCADE MEDTECH LTD is a very young micro-entity currently in the embryonic stage of development. The financial "vitals" suggest it has not yet begun generating operational income or building assets. The directors have injected funds as interest-free loans, recorded as liabilities, which is creating a negative equity position. This "symptom of distress" is typical for startups needing capital injections to establish operations.

The company's financial health resembles a patient in a post-surgery recovery phase—fragile and dependent on external support (director loans) but not yet generating sustainable cash flow. The lack of employees and assets confirms it is still in setup or development rather than active trading.

---

4. Recommendations

• Improve Liquidity: Convert director loans into equity if possible, to strengthen the balance sheet and improve net assets. This would improve financial stability and reduce perceived risk.
• Generate Revenue: Prioritize early sales or service delivery to build current assets (cash/debtors) and reduce reliance on loans.
• Control Expenses: Maintain strict cost discipline until sustainable cash flow is established to avoid increasing liabilities.
• Regular Financial Monitoring: Implement monthly cash flow forecasts and review financial health indicators to detect early warning signs.
• Seek External Funding: Explore grants, seed funding, or venture capital appropriate for medtech startups to support growth without overstretching director resources.
• Legal and Tax Compliance: Ensure all filings remain timely to avoid penalties and maintain company good standing.

---